HEALTH CATALYST, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.03 USD | +7.68% |
|
+8.06% | -34.88% |
| 04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
| 04-10 | KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets | MT |
| Sales 2024 * | 309M 24.7B | Sales 2025 * | 345M 27.59B | Capitalization | 353M 28.27B |
|---|---|---|---|---|---|
| Net income 2024 * | -62M -4.96B | Net income 2025 * | -54M -4.32B | EV / Sales 2024 * | 2.21 x |
| Net Debt 2024 * | 330M 26.4B | Net Debt 2025 * | 311M 24.86B | EV / Sales 2025 * | 1.93 x |
| P/E ratio 2024 * |
-6.08
x | P/E ratio 2025 * |
-7.34
x | Employees | 1,300 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.49% |
More Fundamentals
* Assessed data
More news
Latest transcript on Health Catalyst, Inc.
More recommendations
More press releases
| 1 day | +7.68% | ||
| 1 week | +8.06% | ||
| Current month | -19.92% | ||
| 1 month | -19.49% | ||
| 3 months | -41.46% | ||
| 6 months | -11.06% | ||
| Current year | -34.88% |
1 week
5.45
6.07
1 month
5.457.74
Current year
5.4511.41
1 year
5.4514.37
3 years
5.4559.50
5 years
5.4559.50
10 years
5.4559.50
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Burton
CEO | Chief Executive Officer | 49 | 31/08/11 |
Jason Alger
DFI | Director of Finance/CFO | 40 | 31/03/13 |
Anne Bickmore
COO | Chief Operating Officer | 61 | 30/11/12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John A. Kane
CHM | Chairman | 71 | 14/11/15 |
| Director/Board Member | 64 | 11/05/17 | |
Anita V. Pramoda
BRD | Director/Board Member | 49 | 27/04/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.13% | 16 M€ | -8.49% | ||
| 0.05% | 509 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 6.03 | +7.68% | 692,662 |
| 25/04/24 | 5.6 | -7.13% | 699,349 |
| 24/04/24 | 6.03 | +7.68% | 781,634 |
| 23/04/24 | 5.6 | +0.72% | 493,212 |
| 22/04/24 | 5.56 | -0.36% | 601,349 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Companyâs solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.
Sector
Software
Calendar
08/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
6.03
USD
Average target price
12
USD
Spread / Average Target
+99.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.88% | 353M | |
| -19.95% | 214B | |
| -9.06% | 66.27B | |
| -3.37% | 56.38B | |
| -10.49% | 46.62B | |
| +8.30% | 43.93B | |
| -6.51% | 34.19B | |
| -7.95% | 29.14B | |
| +85.24% | 24.32B | |
| +3.45% | 21.64B |
- Stock Market
- Equities
- HCAT Stock
